Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Cardiovascular Research|August 23, 2011
Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functionsMounia Boulberdaa, Kyoji Urayama, Canan G NebigilScientific Reports|October 18, 2017
Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21+ fibroblast progenitor cell transformation into adipocytes and vascular cellsRehana Qureshi, Michel Kindo, Himanshu Arora, et al.Scientific Reports|May 7, 2016
Prokineticin receptor-1 signaling promotes Epicardial to Mesenchymal Transition during heart developmentHimanshu Arora, Mounia Boulberdaa, Rehana Qureshi, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 17, 2016
Prokineticin receptor 1 is required for mesenchymal-epithelial transition in kidney developmentHimanshu Arora, Mounia Boulberdaa, Rehana Qureshi, et al.Stem Cells (Dayton, Ohio)|June 7, 2018
A Prokineticin-Driven Epigenetic Switch Regulates Human Epicardial Cell Stemness and FateRehana Qureshi, Michel Kindo, Mounia Boulberdaa, et al.Plos One|November 9, 2011
Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27Yohann Bernard, Nigel Ribeiro, Frédéric Thuaud, et al.Plos One|December 11, 2013
Prokineticin receptor 1 as a novel suppressor of preadipocyte proliferation and differentiation to control obesityCécilia Szatkowski, Judith Vallet, Mojdeh Dormishian, et al.Journal of the American Heart Association|October 25, 2013
Prokineticin receptor-1 is a new regulator of endothelial insulin uptake and capillary formation to control insulin sensitivity and cardiovascular and kidney functionsMojdeh Dormishian, Gulen Turkeri, Kyoji Urayama, et al.European Journal of Preventive Cardiology|August 16, 2015
Impaired vascular function and repair in patients with premature coronary artery diseaseMairi Brittan, Amanda Hunter, Mounia Boulberdaa, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 29, 2011
Genetic inactivation of prokineticin receptor-1 leads to heart and kidney disordersMounia Boulberdaa, Gulen Turkeri, Kyoji Urayama, et al.Pageof 2